Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 7—July 2007
Research

Ongoing Genome Reduction in Mycobacterium ulcerans

Simona Rondini*1, Michael Käser*1, Timothy P. Stinear†2, Michel Tessier‡, Cyrill Mangold‡, Gregor Dernick‡, Martin Naegeli*, Françoise Portaels§, Ulrich Certa‡, and Gerd Pluschke*Comments to Author 
Author affiliations: *Swiss Tropical Institute, Basel, Switzerland; †Institut Pasteur, Paris, France; ‡F. Hoffmann-La Roche Ltd., Basel, Switzerland; §Institute of Tropical Medicine, Antwerp, Belgium; 1These authors contributed equally to this work.; 2Current affiliation: Monash University, Melbourne, Victoria, Australia;

Main Article

Table

Features of the 15 distinct deletions identified in Mycobacterium ulcerans isolates*

RDDeletion no.Plasmid no.OriginSize of deletion, kbNo. CDSs and pseudogenes
11p8SU/FG11.114
22p34SU/FG6.6–6.84
33Ap58AU1/AU23.55
3Bp58SU/FG3.86
44p60, p61SU/FG1.8–2.42
55p88, p153, p360ME1/ME227.1–27.423
66p92JP/CH/ME1/ME219.724
77p100SU/FG15.313
88p124, p291ME1/ME252.8–53.150
99Ap144JP/CH18.115
9Bp144SU/FG25.420
1010p170ME1/ME28.2–8.710
1111p305JP/CH4.67
1212Ap315JP/CH53.150
12Bp315SU/FG35.4–35.532

*RD, region of difference; CDSs, coding sequences; SU, Suriname; FG, French Guiana; AU, Australia; ME, Mexico; JP, Japan; CH, China.

Main Article

Page created: June 23, 2010
Page updated: June 23, 2010
Page reviewed: June 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external